MDXG
MIMEDX GROUP, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.97
+0.51%Forward multiples
Based on analyst estimates
- P/E forward
- 31.08x
- P/E 2026E
- —
- P/E 2027E
- 31.74x
- P/E 2028E
- 18.92x
- P/S forward
- 1.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.74x
- Price / sales
- 1.91x
- Price / cash flow
- 27.94x
Enterprise value
- Enterprise value
- $458.6M
- EV / sales
- 1.51x
- EV / EBITDA
- -27.08x
- EV / EBIT
- -18.24x
- Market cap
- $579.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026